Cargando…
Societal costs associated with pulmonary arterial hypertension: A study utilizing linked national registries
Pulmonary arterial hypertension (PAH) is a progressive disease with no cure. Healthcare resource utilization (HCRU; hospitalization, outpatient visits, and drug utilization) before diagnosis and productivity loss (sick leave and disability pension) before and after PAH diagnosis are not well known....
Autores principales: | Runheim, Hannes, Kjellström, Barbro, Beaudet, Amélie, Ivarsson, Bodil, Husberg, Magnus, Pillai, Nadia, Levin, Lars‐Åke, Bernfort, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868346/ https://www.ncbi.nlm.nih.gov/pubmed/36704610 http://dx.doi.org/10.1002/pul2.12190 |
Ejemplares similares
-
Societal costs associated to chronic thromboembolic pulmonary hypertension: A study utilizing linked national registries
por: Kjellström, Barbro, et al.
Publicado: (2023) -
People in states worse than dead according to the EQ-5D UK value set: would they rather be dead?
por: Bernfort, Lars, et al.
Publicado: (2018) -
Implementation of Empagliflozin in Patients with Diabetes Mellitus Type 2 and Established Cardiovascular Disease: Estimation of 5-Year Survival and Costs in Sweden
por: Bernfort, Lars, et al.
Publicado: (2020) -
Disease Burden and Healthcare Costs for T2D Patients With and Without Established Cardiovascular Disease in Sweden: A Retrospective Cohort Study
por: Bernfort, Lars, et al.
Publicado: (2020) -
Prevalence of potential drug–drug interactions with disease‐specific treatments in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A registry study
por: Norell, Puck N., et al.
Publicado: (2022)